About this webinar
Successful T-cell based therapies require properly optimized cell culture media to maximize critical quality attributes such as proliferation, viability, phenotype, and transduction efficiency. The right media can ease development challenges and can impact the speed, manufacturing cost, and quality of a therapeutic dose. In this 15-minute webinar, we will introduce NB-ROC™, a new serum-free T cell media, and will share preliminary data demonstrating the promising performance of this new cell culture media which resulted in threefold improvement in transduction efficiency in internal experimentation.
Our speaker
Asma Ayari, Ph.D.
Research and Development Director
Asma is our Manager of Research and Development. She has extensive experience in media analysis, testing, and formulation for Cell and Gene Therapy. Asma did her Ph.D. work in virology and immunology and brings a deep understanding of how complex cellular systems are affected by small changes in the chemical composition of the microenvironment. Dr. Ayari holds a M.S. in Microbiology from University of Tunis and a Ph.D. in Virology, Immunology and Metabolism from Universite de Lille in France.
Read more
